▶ 調査レポート

薬物移送閉鎖系のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Closed System for Drug Transfer Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。薬物移送閉鎖系のグローバル市場インサイト・予測(~2028年) / Global Closed System for Drug Transfer Market Insights, Forecast to 2028 / QY2203B14013資料のイメージです。• レポートコード:QY2203B14013
• 出版社/出版日:QYResearch / 2022年3月
• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療装置
• 販売価格(消費税別)
  Single User¥735,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,102,500 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,470,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の薬物移送閉鎖系の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に薬物移送閉鎖系の世界市場のxxx%を占める「バイアル用」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の薬物移送閉鎖系の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの薬物移送閉鎖系市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの薬物移送閉鎖系市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

薬物移送閉鎖系のグローバル主要メーカーには、BD Medical, Inc、Equashield、ICU Medical、Simplivia Healthcare Ltd.、Corvida Medical、B. Braunなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

薬物移送閉鎖系市場は、種類と用途によって区分されます。世界の薬物移送閉鎖系市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
バイアル用、シリンジ用、バッグ/ライン用

【用途別セグメント】
病院、診療所

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 薬物移送閉鎖系製品概要
- 種類別市場(バイアル用、シリンジ用、バッグ/ライン用)
- 用途別市場(病院、診療所)
- 調査の目的
・エグゼクティブサマリー
- 世界の薬物移送閉鎖系販売量予測2017-2028
- 世界の薬物移送閉鎖系売上予測2017-2028
- 薬物移送閉鎖系の地域別販売量
- 薬物移送閉鎖系の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別薬物移送閉鎖系販売量
- 主要メーカー別薬物移送閉鎖系売上
- 主要メーカー別薬物移送閉鎖系価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(バイアル用、シリンジ用、バッグ/ライン用)
- 薬物移送閉鎖系の種類別販売量
- 薬物移送閉鎖系の種類別売上
- 薬物移送閉鎖系の種類別価格
・用途別市場規模(病院、診療所)
- 薬物移送閉鎖系の用途別販売量
- 薬物移送閉鎖系の用途別売上
- 薬物移送閉鎖系の用途別価格
・北米市場
- 北米の薬物移送閉鎖系市場規模(種類別、用途別)
- 主要国別の薬物移送閉鎖系市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの薬物移送閉鎖系市場規模(種類別、用途別)
- 主要国別の薬物移送閉鎖系市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の薬物移送閉鎖系市場規模(種類別、用途別)
- 主要国別の薬物移送閉鎖系市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の薬物移送閉鎖系市場規模(種類別、用途別)
- 主要国別の薬物移送閉鎖系市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの薬物移送閉鎖系市場規模(種類別、用途別)
- 主要国別の薬物移送閉鎖系市場規模(トルコ、サウジアラビア)
・企業情報
BD Medical, Inc、Equashield、ICU Medical、Simplivia Healthcare Ltd.、Corvida Medical、B. Braun
・産業チェーン及び販売チャネル分析
- 薬物移送閉鎖系の産業チェーン分析
- 薬物移送閉鎖系の原材料
- 薬物移送閉鎖系の生産プロセス
- 薬物移送閉鎖系の販売及びマーケティング
- 薬物移送閉鎖系の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 薬物移送閉鎖系の産業動向
- 薬物移送閉鎖系のマーケットドライバー
- 薬物移送閉鎖系の課題
- 薬物移送閉鎖系の阻害要因
・主な調査結果

Market Analysis and Insights: Global Closed System for Drug Transfer Market
Due to the COVID-19 pandemic, the global Closed System for Drug Transfer market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, for Vial accounting for % of the Closed System for Drug Transfer global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Closed System for Drug Transfer market size is valued at US$ million in 2021, while the US and Europe Closed System for Drug Transfer are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Closed System for Drug Transfer landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Closed System for Drug Transfer include BD Medical, Inc, Equashield, ICU Medical, Simplivia Healthcare Ltd., Corvida Medical and B. Braun, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Closed System for Drug Transfer Scope and Segment
Closed System for Drug Transfer market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Closed System for Drug Transfer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
for Vial
for Syringe
for Bag/Line
Segment by Application
Hospitals
Clinics
By Company
BD Medical, Inc
Equashield
ICU Medical
Simplivia Healthcare Ltd.
Corvida Medical
B. Braun
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Closed System for Drug Transfer Product Introduction
1.2 Market by Type
1.2.1 Global Closed System for Drug Transfer Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 for Vial
1.2.3 for Syringe
1.2.4 for Bag/Line
1.3 Market by Application
1.3.1 Global Closed System for Drug Transfer Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Closed System for Drug Transfer Sales Estimates and Forecasts 2017-2028
2.2 Global Closed System for Drug Transfer Revenue Estimates and Forecasts 2017-2028
2.3 Global Closed System for Drug Transfer Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Closed System for Drug Transfer Sales by Region
2.4.1 Global Closed System for Drug Transfer Sales by Region (2017-2022)
2.4.2 Global Sales Closed System for Drug Transfer by Region (2023-2028)
2.5 Global Closed System for Drug Transfer Revenue by Region
2.5.1 Global Closed System for Drug Transfer Revenue by Region (2017-2022)
2.5.2 Global Closed System for Drug Transfer Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Closed System for Drug Transfer Sales by Manufacturers
3.1.1 Global Top Closed System for Drug Transfer Manufacturers by Sales (2017-2022)
3.1.2 Global Closed System for Drug Transfer Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Closed System for Drug Transfer in 2021
3.2 Global Closed System for Drug Transfer Revenue by Manufacturers
3.2.1 Global Closed System for Drug Transfer Revenue by Manufacturers (2017-2022)
3.2.2 Global Closed System for Drug Transfer Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Closed System for Drug Transfer Revenue in 2021
3.3 Global Closed System for Drug Transfer Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Closed System for Drug Transfer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Closed System for Drug Transfer Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Closed System for Drug Transfer Sales by Type
4.1.1 Global Closed System for Drug Transfer Historical Sales by Type (2017-2022)
4.1.2 Global Closed System for Drug Transfer Forecasted Sales by Type (2023-2028)
4.1.3 Global Closed System for Drug Transfer Sales Market Share by Type (2017-2028)
4.2 Global Closed System for Drug Transfer Revenue by Type
4.2.1 Global Closed System for Drug Transfer Historical Revenue by Type (2017-2022)
4.2.2 Global Closed System for Drug Transfer Forecasted Revenue by Type (2023-2028)
4.2.3 Global Closed System for Drug Transfer Revenue Market Share by Type (2017-2028)
4.3 Global Closed System for Drug Transfer Price by Type
4.3.1 Global Closed System for Drug Transfer Price by Type (2017-2022)
4.3.2 Global Closed System for Drug Transfer Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Closed System for Drug Transfer Sales by Application
5.1.1 Global Closed System for Drug Transfer Historical Sales by Application (2017-2022)
5.1.2 Global Closed System for Drug Transfer Forecasted Sales by Application (2023-2028)
5.1.3 Global Closed System for Drug Transfer Sales Market Share by Application (2017-2028)
5.2 Global Closed System for Drug Transfer Revenue by Application
5.2.1 Global Closed System for Drug Transfer Historical Revenue by Application (2017-2022)
5.2.2 Global Closed System for Drug Transfer Forecasted Revenue by Application (2023-2028)
5.2.3 Global Closed System for Drug Transfer Revenue Market Share by Application (2017-2028)
5.3 Global Closed System for Drug Transfer Price by Application
5.3.1 Global Closed System for Drug Transfer Price by Application (2017-2022)
5.3.2 Global Closed System for Drug Transfer Price Forecast by Application (2023-2028)
6 North America
6.1 North America Closed System for Drug Transfer Market Size by Type
6.1.1 North America Closed System for Drug Transfer Sales by Type (2017-2028)
6.1.2 North America Closed System for Drug Transfer Revenue by Type (2017-2028)
6.2 North America Closed System for Drug Transfer Market Size by Application
6.2.1 North America Closed System for Drug Transfer Sales by Application (2017-2028)
6.2.2 North America Closed System for Drug Transfer Revenue by Application (2017-2028)
6.3 North America Closed System for Drug Transfer Market Size by Country
6.3.1 North America Closed System for Drug Transfer Sales by Country (2017-2028)
6.3.2 North America Closed System for Drug Transfer Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Closed System for Drug Transfer Market Size by Type
7.1.1 Europe Closed System for Drug Transfer Sales by Type (2017-2028)
7.1.2 Europe Closed System for Drug Transfer Revenue by Type (2017-2028)
7.2 Europe Closed System for Drug Transfer Market Size by Application
7.2.1 Europe Closed System for Drug Transfer Sales by Application (2017-2028)
7.2.2 Europe Closed System for Drug Transfer Revenue by Application (2017-2028)
7.3 Europe Closed System for Drug Transfer Market Size by Country
7.3.1 Europe Closed System for Drug Transfer Sales by Country (2017-2028)
7.3.2 Europe Closed System for Drug Transfer Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Closed System for Drug Transfer Market Size by Type
8.1.1 Asia Pacific Closed System for Drug Transfer Sales by Type (2017-2028)
8.1.2 Asia Pacific Closed System for Drug Transfer Revenue by Type (2017-2028)
8.2 Asia Pacific Closed System for Drug Transfer Market Size by Application
8.2.1 Asia Pacific Closed System for Drug Transfer Sales by Application (2017-2028)
8.2.2 Asia Pacific Closed System for Drug Transfer Revenue by Application (2017-2028)
8.3 Asia Pacific Closed System for Drug Transfer Market Size by Region
8.3.1 Asia Pacific Closed System for Drug Transfer Sales by Region (2017-2028)
8.3.2 Asia Pacific Closed System for Drug Transfer Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Closed System for Drug Transfer Market Size by Type
9.1.1 Latin America Closed System for Drug Transfer Sales by Type (2017-2028)
9.1.2 Latin America Closed System for Drug Transfer Revenue by Type (2017-2028)
9.2 Latin America Closed System for Drug Transfer Market Size by Application
9.2.1 Latin America Closed System for Drug Transfer Sales by Application (2017-2028)
9.2.2 Latin America Closed System for Drug Transfer Revenue by Application (2017-2028)
9.3 Latin America Closed System for Drug Transfer Market Size by Country
9.3.1 Latin America Closed System for Drug Transfer Sales by Country (2017-2028)
9.3.2 Latin America Closed System for Drug Transfer Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Closed System for Drug Transfer Market Size by Type
10.1.1 Middle East and Africa Closed System for Drug Transfer Sales by Type (2017-2028)
10.1.2 Middle East and Africa Closed System for Drug Transfer Revenue by Type (2017-2028)
10.2 Middle East and Africa Closed System for Drug Transfer Market Size by Application
10.2.1 Middle East and Africa Closed System for Drug Transfer Sales by Application (2017-2028)
10.2.2 Middle East and Africa Closed System for Drug Transfer Revenue by Application (2017-2028)
10.3 Middle East and Africa Closed System for Drug Transfer Market Size by Country
10.3.1 Middle East and Africa Closed System for Drug Transfer Sales by Country (2017-2028)
10.3.2 Middle East and Africa Closed System for Drug Transfer Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 BD Medical, Inc
11.1.1 BD Medical, Inc Corporation Information
11.1.2 BD Medical, Inc Overview
11.1.3 BD Medical, Inc Closed System for Drug Transfer Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 BD Medical, Inc Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 BD Medical, Inc Recent Developments
11.2 Equashield
11.2.1 Equashield Corporation Information
11.2.2 Equashield Overview
11.2.3 Equashield Closed System for Drug Transfer Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Equashield Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Equashield Recent Developments
11.3 ICU Medical
11.3.1 ICU Medical Corporation Information
11.3.2 ICU Medical Overview
11.3.3 ICU Medical Closed System for Drug Transfer Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ICU Medical Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ICU Medical Recent Developments
11.4 Simplivia Healthcare Ltd.
11.4.1 Simplivia Healthcare Ltd. Corporation Information
11.4.2 Simplivia Healthcare Ltd. Overview
11.4.3 Simplivia Healthcare Ltd. Closed System for Drug Transfer Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Simplivia Healthcare Ltd. Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Simplivia Healthcare Ltd. Recent Developments
11.5 Corvida Medical
11.5.1 Corvida Medical Corporation Information
11.5.2 Corvida Medical Overview
11.5.3 Corvida Medical Closed System for Drug Transfer Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Corvida Medical Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Corvida Medical Recent Developments
11.6 B. Braun
11.6.1 B. Braun Corporation Information
11.6.2 B. Braun Overview
11.6.3 B. Braun Closed System for Drug Transfer Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 B. Braun Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 B. Braun Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Closed System for Drug Transfer Industry Chain Analysis
12.2 Closed System for Drug Transfer Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Closed System for Drug Transfer Production Mode & Process
12.4 Closed System for Drug Transfer Sales and Marketing
12.4.1 Closed System for Drug Transfer Sales Channels
12.4.2 Closed System for Drug Transfer Distributors
12.5 Closed System for Drug Transfer Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Closed System for Drug Transfer Industry Trends
13.2 Closed System for Drug Transfer Market Drivers
13.3 Closed System for Drug Transfer Market Challenges
13.4 Closed System for Drug Transfer Market Restraints
14 Key Findings in The Global Closed System for Drug Transfer Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Closed System for Drug Transfer Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of for Vial
Table 3. Major Manufacturers of for Syringe
Table 4. Major Manufacturers of for Bag/Line
Table 5. Global Closed System for Drug Transfer Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Closed System for Drug Transfer Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Closed System for Drug Transfer Sales by Region (2017-2022) & (Million Units)
Table 8. Global Closed System for Drug Transfer Sales Market Share by Region (2017-2022)
Table 9. Global Closed System for Drug Transfer Sales by Region (2023-2028) & (Million Units)
Table 10. Global Closed System for Drug Transfer Sales Market Share by Region (2023-2028)
Table 11. Global Closed System for Drug Transfer Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Closed System for Drug Transfer Revenue Market Share by Region (2017-2022)
Table 13. Global Closed System for Drug Transfer Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Closed System for Drug Transfer Revenue Market Share by Region (2023-2028)
Table 15. Global Closed System for Drug Transfer Sales by Manufacturers (2017-2022) & (Million Units)
Table 16. Global Closed System for Drug Transfer Sales Share by Manufacturers (2017-2022)
Table 17. Global Closed System for Drug Transfer Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Closed System for Drug Transfer Revenue Share by Manufacturers (2017-2022)
Table 19. Closed System for Drug Transfer Price by Manufacturers (2017-2022) &(US$/K Units)
Table 20. Global Closed System for Drug Transfer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Closed System for Drug Transfer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Closed System for Drug Transfer as of 2021)
Table 22. Closed System for Drug Transfer Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Closed System for Drug Transfer Product Offered
Table 24. Date of Manufacturers Enter into Closed System for Drug Transfer Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Closed System for Drug Transfer Sales by Type (2017-2022) & (Million Units)
Table 27. Global Closed System for Drug Transfer Sales by Type (2023-2028) & (Million Units)
Table 28. Global Closed System for Drug Transfer Sales Share by Type (2017-2022)
Table 29. Global Closed System for Drug Transfer Sales Share by Type (2023-2028)
Table 30. Global Closed System for Drug Transfer Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Closed System for Drug Transfer Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Closed System for Drug Transfer Revenue Share by Type (2017-2022)
Table 33. Global Closed System for Drug Transfer Revenue Share by Type (2023-2028)
Table 34. Closed System for Drug Transfer Price by Type (2017-2022) & (US$/K Units)
Table 35. Global Closed System for Drug Transfer Price Forecast by Type (2023-2028) & (US$/K Units)
Table 36. Global Closed System for Drug Transfer Sales by Application (2017-2022) & (Million Units)
Table 37. Global Closed System for Drug Transfer Sales by Application (2023-2028) & (Million Units)
Table 38. Global Closed System for Drug Transfer Sales Share by Application (2017-2022)
Table 39. Global Closed System for Drug Transfer Sales Share by Application (2023-2028)
Table 40. Global Closed System for Drug Transfer Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Closed System for Drug Transfer Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Closed System for Drug Transfer Revenue Share by Application (2017-2022)
Table 43. Global Closed System for Drug Transfer Revenue Share by Application (2023-2028)
Table 44. Closed System for Drug Transfer Price by Application (2017-2022) & (US$/K Units)
Table 45. Global Closed System for Drug Transfer Price Forecast by Application (2023-2028) & (US$/K Units)
Table 46. North America Closed System for Drug Transfer Sales by Type (2017-2022) & (Million Units)
Table 47. North America Closed System for Drug Transfer Sales by Type (2023-2028) & (Million Units)
Table 48. North America Closed System for Drug Transfer Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Closed System for Drug Transfer Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Closed System for Drug Transfer Sales by Application (2017-2022) & (Million Units)
Table 51. North America Closed System for Drug Transfer Sales by Application (2023-2028) & (Million Units)
Table 52. North America Closed System for Drug Transfer Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Closed System for Drug Transfer Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Closed System for Drug Transfer Sales by Country (2017-2022) & (Million Units)
Table 55. North America Closed System for Drug Transfer Sales by Country (2023-2028) & (Million Units)
Table 56. North America Closed System for Drug Transfer Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Closed System for Drug Transfer Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Closed System for Drug Transfer Sales by Type (2017-2022) & (Million Units)
Table 59. Europe Closed System for Drug Transfer Sales by Type (2023-2028) & (Million Units)
Table 60. Europe Closed System for Drug Transfer Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Closed System for Drug Transfer Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Closed System for Drug Transfer Sales by Application (2017-2022) & (Million Units)
Table 63. Europe Closed System for Drug Transfer Sales by Application (2023-2028) & (Million Units)
Table 64. Europe Closed System for Drug Transfer Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Closed System for Drug Transfer Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Closed System for Drug Transfer Sales by Country (2017-2022) & (Million Units)
Table 67. Europe Closed System for Drug Transfer Sales by Country (2023-2028) & (Million Units)
Table 68. Europe Closed System for Drug Transfer Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Closed System for Drug Transfer Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Closed System for Drug Transfer Sales by Type (2017-2022) & (Million Units)
Table 71. Asia Pacific Closed System for Drug Transfer Sales by Type (2023-2028) & (Million Units)
Table 72. Asia Pacific Closed System for Drug Transfer Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Closed System for Drug Transfer Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Closed System for Drug Transfer Sales by Application (2017-2022) & (Million Units)
Table 75. Asia Pacific Closed System for Drug Transfer Sales by Application (2023-2028) & (Million Units)
Table 76. Asia Pacific Closed System for Drug Transfer Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Closed System for Drug Transfer Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Closed System for Drug Transfer Sales by Region (2017-2022) & (Million Units)
Table 79. Asia Pacific Closed System for Drug Transfer Sales by Region (2023-2028) & (Million Units)
Table 80. Asia Pacific Closed System for Drug Transfer Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Closed System for Drug Transfer Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Closed System for Drug Transfer Sales by Type (2017-2022) & (Million Units)
Table 83. Latin America Closed System for Drug Transfer Sales by Type (2023-2028) & (Million Units)
Table 84. Latin America Closed System for Drug Transfer Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Closed System for Drug Transfer Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Closed System for Drug Transfer Sales by Application (2017-2022) & (Million Units)
Table 87. Latin America Closed System for Drug Transfer Sales by Application (2023-2028) & (Million Units)
Table 88. Latin America Closed System for Drug Transfer Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Closed System for Drug Transfer Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Closed System for Drug Transfer Sales by Country (2017-2022) & (Million Units)
Table 91. Latin America Closed System for Drug Transfer Sales by Country (2023-2028) & (Million Units)
Table 92. Latin America Closed System for Drug Transfer Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Closed System for Drug Transfer Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Closed System for Drug Transfer Sales by Type (2017-2022) & (Million Units)
Table 95. Middle East and Africa Closed System for Drug Transfer Sales by Type (2023-2028) & (Million Units)
Table 96. Middle East and Africa Closed System for Drug Transfer Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Closed System for Drug Transfer Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Closed System for Drug Transfer Sales by Application (2017-2022) & (Million Units)
Table 99. Middle East and Africa Closed System for Drug Transfer Sales by Application (2023-2028) & (Million Units)
Table 100. Middle East and Africa Closed System for Drug Transfer Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Closed System for Drug Transfer Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Closed System for Drug Transfer Sales by Country (2017-2022) & (Million Units)
Table 103. Middle East and Africa Closed System for Drug Transfer Sales by Country (2023-2028) & (Million Units)
Table 104. Middle East and Africa Closed System for Drug Transfer Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Closed System for Drug Transfer Revenue by Country (2023-2028) & (US$ Million)
Table 106. BD Medical, Inc Corporation Information
Table 107. BD Medical, Inc Description and Major Businesses
Table 108. BD Medical, Inc Closed System for Drug Transfer Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 109. BD Medical, Inc Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. BD Medical, Inc Recent Developments
Table 111. Equashield Corporation Information
Table 112. Equashield Description and Major Businesses
Table 113. Equashield Closed System for Drug Transfer Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 114. Equashield Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Equashield Recent Developments
Table 116. ICU Medical Corporation Information
Table 117. ICU Medical Description and Major Businesses
Table 118. ICU Medical Closed System for Drug Transfer Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 119. ICU Medical Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. ICU Medical Recent Developments
Table 121. Simplivia Healthcare Ltd. Corporation Information
Table 122. Simplivia Healthcare Ltd. Description and Major Businesses
Table 123. Simplivia Healthcare Ltd. Closed System for Drug Transfer Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 124. Simplivia Healthcare Ltd. Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Simplivia Healthcare Ltd. Recent Developments
Table 126. Corvida Medical Corporation Information
Table 127. Corvida Medical Description and Major Businesses
Table 128. Corvida Medical Closed System for Drug Transfer Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 129. Corvida Medical Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Corvida Medical Recent Developments
Table 131. B. Braun Corporation Information
Table 132. B. Braun Description and Major Businesses
Table 133. B. Braun Closed System for Drug Transfer Sales (Million Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2017-2022)
Table 134. B. Braun Closed System for Drug Transfer Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. B. Braun Recent Developments
Table 136. Key Raw Materials Lists
Table 137. Raw Materials Key Suppliers Lists
Table 138. Closed System for Drug Transfer Distributors List
Table 139. Closed System for Drug Transfer Customers List
Table 140. Closed System for Drug Transfer Market Trends
Table 141. Closed System for Drug Transfer Market Drivers
Table 142. Closed System for Drug Transfer Market Challenges
Table 143. Closed System for Drug Transfer Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Closed System for Drug Transfer Product Picture
Figure 3. Global Closed System for Drug Transfer Market Share by Type in 2021 & 2028
Figure 3. for Vial Product Picture
Figure 4. for Syringe Product Picture
Figure 5. for Bag/Line Product Picture
Figure 6. Global Closed System for Drug Transfer Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Closed System for Drug Transfer Report Years Considered
Figure 10. Global Closed System for Drug Transfer Sales 2017-2028 (Million Units)
Figure 11. Global Closed System for Drug Transfer Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Closed System for Drug Transfer Revenue 2017-2028 (US$ Million)
Figure 13. Global Closed System for Drug Transfer Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Closed System for Drug Transfer Sales Market Share by Region (2017-2022)
Figure 15. Global Closed System for Drug Transfer Sales Market Share by Region (2023-2028)
Figure 16. North America Closed System for Drug Transfer Sales YoY (2017-2028) & (Million Units)
Figure 17. North America Closed System for Drug Transfer Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Closed System for Drug Transfer Sales YoY (2017-2028) & (Million Units)
Figure 19. Europe Closed System for Drug Transfer Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Closed System for Drug Transfer Sales YoY (2017-2028) & (Million Units)
Figure 21. Asia-Pacific Closed System for Drug Transfer Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Closed System for Drug Transfer Sales YoY (2017-2028) & (Million Units)
Figure 23. Latin America Closed System for Drug Transfer Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Closed System for Drug Transfer Sales YoY (2017-2028) & (Million Units)
Figure 25. Middle East & Africa Closed System for Drug Transfer Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Closed System for Drug Transfer Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Closed System for Drug Transfer in the World: Market Share by Closed System for Drug Transfer Revenue in 2021
Figure 28. Global Closed System for Drug Transfer Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Closed System for Drug Transfer Sales Market Share by Type (2017-2028)
Figure 30. Global Closed System for Drug Transfer Revenue Market Share by Type (2017-2028)
Figure 31. Global Closed System for Drug Transfer Sales Market Share by Application (2017-2028)
Figure 32. Global Closed System for Drug Transfer Revenue Market Share by Application (2017-2028)
Figure 33. North America Closed System for Drug Transfer Sales Market Share by Type (2017-2028)
Figure 34. North America Closed System for Drug Transfer Revenue Market Share by Type (2017-2028)
Figure 35. North America Closed System for Drug Transfer Sales Market Share by Application (2017-2028)
Figure 36. North America Closed System for Drug Transfer Revenue Market Share by Application (2017-2028)
Figure 37. North America Closed System for Drug Transfer Sales Share by Country (2017-2028)
Figure 38. North America Closed System for Drug Transfer Revenue Share by Country (2017-2028)
Figure 39. United States Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Closed System for Drug Transfer Sales Market Share by Type (2017-2028)
Figure 42. Europe Closed System for Drug Transfer Revenue Market Share by Type (2017-2028)
Figure 43. Europe Closed System for Drug Transfer Sales Market Share by Application (2017-2028)
Figure 44. Europe Closed System for Drug Transfer Revenue Market Share by Application (2017-2028)
Figure 45. Europe Closed System for Drug Transfer Sales Share by Country (2017-2028)
Figure 46. Europe Closed System for Drug Transfer Revenue Share by Country (2017-2028)
Figure 47. Germany Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 48. France Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Closed System for Drug Transfer Sales Market Share by Type (2017-2028)
Figure 53. Asia Pacific Closed System for Drug Transfer Revenue Market Share by Type (2017-2028)
Figure 54. Asia Pacific Closed System for Drug Transfer Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Closed System for Drug Transfer Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Closed System for Drug Transfer Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Closed System for Drug Transfer Revenue Share by Region (2017-2028)
Figure 58. China Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 61. India Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Closed System for Drug Transfer Sales Market Share by Type (2017-2028)
Figure 68. Latin America Closed System for Drug Transfer Revenue Market Share by Type (2017-2028)
Figure 69. Latin America Closed System for Drug Transfer Sales Market Share by Application (2017-2028)
Figure 70. Latin America Closed System for Drug Transfer Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Closed System for Drug Transfer Sales Share by Country (2017-2028)
Figure 72. Latin America Closed System for Drug Transfer Revenue Share by Country (2017-2028)
Figure 73. Mexico Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Closed System for Drug Transfer Sales Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Closed System for Drug Transfer Revenue Market Share by Type (2017-2028)
Figure 78. Middle East and Africa Closed System for Drug Transfer Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Closed System for Drug Transfer Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Closed System for Drug Transfer Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Closed System for Drug Transfer Revenue Share by Country (2017-2028)
Figure 82. Turkey Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Closed System for Drug Transfer Revenue (2017-2028) & (US$ Million)
Figure 85. Closed System for Drug Transfer Value Chain
Figure 86. Closed System for Drug Transfer Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed